Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TNBC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07178171
What this trial is testing

QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

Who this might be right for
TNBC, Triple Negative Breast Cancer
Xijing Hospital 30
Very early researchLooking for participantsNCT06637306
What this trial is testing

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Who this might be right for
Locally Advanced Triple Negative Breast CancerTNBC - Triple-Negative Breast Cancer
Rima Patel 15
Not applicableUnknownNCT02012634
What this trial is testing

Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer

Who this might be right for
Breast CancerCapecitabineTriple Negative Breast Cancer
Xijing Hospital 340
Testing effectiveness (Phase 2)Ended earlyNCT03358004
What this trial is testing

The Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment

Who this might be right for
Triple Negative Breast Cancer
Mario Negri Institute for Pharmacological Research 4
Early research (Phase 1)Active Not RecruitingNCT06036121
What this trial is testing

ADRX-0706 in Select Advanced Solid Tumors

Who this might be right for
Solid TumorsTriple Negative Breast Cancer (TNBC)Urothelial Cancer+1 more
Adcentrx Therapeutics 144
Large-scale testing (Phase 3)Looking for participantsNCT05999149
What this trial is testing

Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 424
Early research (Phase 1)Active Not RecruitingNCT03893955
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerAdvanced Solid TumorsTriple-Negative Breast Cancer (TNBC)+2 more
AbbVie 150
Early research (Phase 1)Looking for participantsNCT06246968
What this trial is testing

Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast CancerBreast Cancer Stage IV+5 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06078384
What this trial is testing

Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC

Who this might be right for
Triple-negative Breast Cancer
UNICANCER 354
Testing effectiveness (Phase 2)UnknownNCT04634747
What this trial is testing

Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer

Who this might be right for
Metastatic Triple-Negative Breast Carcinoma
OncoPep, Inc. 53
Testing effectiveness (Phase 2)WithdrawnNCT03554109
What this trial is testing

QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine

Who this might be right for
Triple Negative Breast Cancer (TNBC)
ImmunityBio, Inc.
Early research (Phase 1)Study completedNCT03945604
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC

Who this might be right for
Triple Negative Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 32
Not applicableLooking for participantsNCT07619534
What this trial is testing

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

Who this might be right for
Breast CancerBreast CarcinomaCancer of the Breast+1 more
National Cancer Institute (NCI) 139
Not applicableStudy completedNCT03911219
What this trial is testing

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

Who this might be right for
Stage IV Non-small Cell Lung CancerExtensive-stage Small Cell Lung CancerAdvanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC
iOMEDICO AG 154
Not applicableStudy completedNCT04541420
What this trial is testing

Eribulin in mTNBC Patients

Who this might be right for
Breast Cancer
Fudan University 208
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05862610
What this trial is testing

The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC

Who this might be right for
Breast Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 150
Large-scale testing (Phase 3)Looking for participantsNCT06393374
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Who this might be right for
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC 1,530
Testing effectiveness (Phase 2)Looking for participantsNCT05064280
What this trial is testing

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

Who this might be right for
Brain MetastasesTumor
M.D. Anderson Cancer Center 104
Early research (Phase 1)Study completedNCT03109080
What this trial is testing

Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Neoplasms, Triple-NegativeBreast Neoplasm Malignant FemaleRadiotherapy Side Effect
Institut Curie 24
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Next Page